RVTY
Revvity Inc.

783
Loading...
Loading...
News
all
press releases
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’
Healthcare providers are opting for fewer multiplex diagnostic products, the CEO said, while noting that this trend is likely to drive volume for single-plex tests.
Stocktwits·1mo ago
News Placeholder
More News
News Placeholder
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today
Tesla’s shares continued to rise on Monday, extending the surge from Friday after the company announced a $16.5 billion partnership with Samsung Electronics for semiconductor chips.
Stocktwits·1mo ago
News Placeholder
RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View
Revvity's second-quarter results showcase strong growth in its Diagnostics business, along with recovery in Life Sciences segmental sales.
Zacks·1mo ago
News Placeholder
Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Revvity (RVTY) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·1mo ago
News Placeholder
Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates
Revvity (RVTY) delivered earnings and revenue surprises of +3.51% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Why Revvity (RVTY) is Poised to Beat Earnings Estimates Again
Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·1mo ago
News Placeholder
Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat?
RVTY is likely to see another earnings beat as Diagnostics momentum and Signals Software growth offset tariff headwinds.
Zacks·2mo ago
News Placeholder
Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings
Beyond analysts' top-and-bottom-line estimates for Revvity (RVTY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Zacks·2mo ago
News Placeholder
GeneDx Holdings Corp. (WGS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
GENEDX HOLDINGS (WGS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago

Latest RVTY News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.